These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 20596118

  • 1. [Hyperkalemia, heart failure and reduced renal function].
    Bugge JF.
    Tidsskr Nor Laegeforen; 2010 Jul 01; 130(13):1354-5. PubMed ID: 20596118
    [No Abstract] [Full Text] [Related]

  • 2. [An elderly man with known heart failure admitted with cardiogenic shock].
    Hovland A, Fagerheim AK, Hardersen R, Nielsen EW.
    Tidsskr Nor Laegeforen; 2010 Jul 01; 130(13):1352-4. PubMed ID: 20596117
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 01; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 4. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
    Weir MR, Rolfe M.
    Clin J Am Soc Nephrol; 2010 Mar 01; 5(3):531-48. PubMed ID: 20150448
    [Abstract] [Full Text] [Related]

  • 5. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
    Jneid H, Moukarbel GV, Dawson B, Hajjar RJ, Francis GS.
    Am J Med; 2007 Dec 01; 120(12):1090.e1-8. PubMed ID: 18060931
    [Abstract] [Full Text] [Related]

  • 6. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ, Pfeffer MA, Swedberg K, Dzau VJ.
    Circulation; 2004 Nov 16; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract] [Full Text] [Related]

  • 7. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
    Fuster D, Frey FJ, Ferrari P.
    Praxis (Bern 1994); 2000 Dec 07; 89(49):2073-6. PubMed ID: 11190849
    [Abstract] [Full Text] [Related]

  • 8. [Finely adjusted differential therapy succeeds this way! References for dose adjustments in heart failure (interview by Dr. Dirk Einecke)].
    Erdmann E.
    MMW Fortschr Med; 2005 Sep 29; 147(39):11. PubMed ID: 16245770
    [No Abstract] [Full Text] [Related]

  • 9. Hyperkalemia risk and treatment of heart failure.
    Segura J, Ruilope LM.
    Heart Fail Clin; 2008 Oct 29; 4(4):455-64. PubMed ID: 18760757
    [Abstract] [Full Text] [Related]

  • 10. [Pharmocological therapeutics for chronic heart failure--how to use ARB (angiotensin receptor blocker].
    Kudo Y, Komuro I, Akazawa H.
    Nihon Rinsho; 2007 May 28; 65 Suppl 5():84-9. PubMed ID: 17571370
    [No Abstract] [Full Text] [Related]

  • 11. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP, Aaronson KD, Koelling TM.
    Am Heart J; 2004 Dec 28; 148(6):971-8. PubMed ID: 15632880
    [Abstract] [Full Text] [Related]

  • 12. [Hypotension associated with heart failure].
    Fujita H.
    Nihon Rinsho; 2007 May 28; 65 Suppl 5():375-82. PubMed ID: 17571409
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of heart failure with spironolactone--trial and tribulations.
    McMurray JJ, O'Meara E.
    N Engl J Med; 2004 Aug 05; 351(6):526-8. PubMed ID: 15295043
    [No Abstract] [Full Text] [Related]

  • 14. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
    Rapp JA, Gheorghiade M.
    Cardiol Clin; 2008 Feb 05; 26(1):23-40, vi. PubMed ID: 18312903
    [Abstract] [Full Text] [Related]

  • 15. [Therapy of heart failure. Which patients does the AT1 blocker help?].
    Böhm M.
    MMW Fortschr Med; 2003 Sep 18; 145(38):8. PubMed ID: 14603671
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers.
    Norgard NB, Stark JE.
    Pharmacotherapy; 2008 Jul 18; 28(7):920-31. PubMed ID: 18576907
    [Abstract] [Full Text] [Related]

  • 17. Traditional and novel approaches to management of heart failure: successes and failures.
    Anand IS, Florea VG.
    Cardiol Clin; 2008 Feb 18; 26(1):59-72, vi. PubMed ID: 18312906
    [Abstract] [Full Text] [Related]

  • 18. Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.
    Erden I, Yalcin S, Ozhan H.
    Kardiol Pol; 2010 Sep 18; 68(9):1043-5; discussion 1046. PubMed ID: 20859899
    [Abstract] [Full Text] [Related]

  • 19. [Therapy of heart failure. 2 neurohormone blockers are enough].
    MMW Fortschr Med; 2002 Sep 05; 144(35-36):57. PubMed ID: 12380364
    [No Abstract] [Full Text] [Related]

  • 20. Study warns of danger of combining spironolactone and ACE inhibitors in heart patients.
    Gottlieb S.
    BMJ; 2004 Aug 21; 329(7463):420. PubMed ID: 15321896
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.